XTEK goes after big fish
XTEK Limited (ASX:XTE) is going after a big fish – aiming to supply the Australian Army with 78 “small unmanned aircraft systems”.
XTEK has told its shareholders that it has responded to an open tender put out by the Army last year.
The contract will include supply of the aerial vehicles, training, repair, and spares support post-acquisition.
The potential value of the tender hasn’t been worked out yet, but it expected the contract will roll on in April to July next year.
Should XTEK be successful it would be a further fillip for its unmaned aerial vehicle (UAV) unit, which got a boost last year when it moved to acquire Simmersion Holdings.
Simmersion Holdings is a 3D mapping business, and at the time XTEK eyed using its UAV’s to take data from the sky to provide to urban planners.
In other XTEK news, it said it had been named as a preferred tenderer on the supply of tactical bomb response equipment to an unnamed government client.
The contracts have the potential to bring in more than $1 million, but they still need to be worked through and the money to be signed off by the federal Government.
More about XTEK
XTEK develops, builds and sells its own hardware but to ensure a vast range of solutions, XTEK also imports and distributes a range of other products. Overall, XTEK supplies over a hundred different products ranging from rifles to explosives detection kits.
XTEK’s proprietary technology has been branded as XTclave and XTatlas.
XTclave is a manufacturing technology to make more effective bullet proof composites. This can be used in personal body armour, helmets, aircraft and vehicle components which are typically used by the Military.
XTatlas is a tool that generates detailed aerial imagery and superimposes it onto existing maps such as Google Maps.
Together, XTclave and XTatlas are unique and proprietary to XTEK with the US and Australian authorities already doing business with XTEK.
In 2014-15, XTEK’s revenues topped $12M with the company becoming cash flow positive and profitable after cost, for the first time last year.
Short-term positions in small, early stage ASX companies,
with high potential and near term price catalysts.
Focusing on resource exploration, early-stage tech, and biotech.
Exceptional opportunities across a broad range of
early-stage growth sectors with strong management.
Seeking 1,000% plus returns across medium to long-term holds.
Longer-term positions in a variety of sectors.
Seeking strong management where traction is established and have entered into a growth phase.
S3 Consortium Pty Ltd (CAR No.433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information only. Any advice is general advice only. Neither your personal objectives, financial situation nor needs have been taken into consideration. Accordingly you should consider how appropriate the advice (if any) is to those objectives, financial situation and needs, before acting on the advice.
Conflict of Interest Notice
S3 Consortium Pty Ltd does and seeks to do business with companies featured in its articles. As a result, investors should be aware that the Firm may have a conflict of interest that could affect the objectivity of this article. Investors should consider this article as only a single factor in making any investment decision. The publishers of this article also wish to disclose that they may hold this stock in their portfolios and that any decision to purchase this stock should be done so after the purchaser has made their own inquires as to the validity of any information in this article.
The information contained in this article is current at the finalised date. The information contained in this article is based on sources reasonably considered to be reliable by S3 Consortium Pty Ltd, and available in the public domain. No “insider information” is ever sourced, disclosed or used by S3 Consortium.